Amphastar Pharmaceuticals, Inc.
Price Action
Technical Summary
WEAKENINGAmphastar Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 22), showing significant lag compared to the market leaders. Earnings contraction of 73% provides fundamental context to the price action. Investors should exercise caution due to high volatility (55% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $20.02 | +0.30% | ABOVE |
| 50 SMA | $19.83 | +1.27% | ABOVE |
| 100 SMA | $20.85 | -3.69% | BELOW |
| 150 SMA | $22.89 | -12.28% | BELOW |
| 200 SMA | $23.57 | -14.82% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is AMPH in an uptrend right now?
AMPH has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is AMPH overbought or oversold?
AMPH's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.
Is AMPH outperforming the market?
AMPH has a Relative Strength (RS) Rating of 22 out of 99. AMPH is currently lagging the broader market.
Where is AMPH in its 52-week range?
AMPH is trading at $20.08, which is 64% of its 52-week high ($31.26) and 24% above its 52-week low ($16.64).
How volatile is AMPH?
AMPH has a Beta of 0.82 and 52-week volatility of 55%. It's less volatile than the S&P 500 - generally more stable.